Study guide
Typical optic neuritis and ONTT
European Board of Ophthalmology Diploma EBOD
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: EBOD Examination, Applications and Regulations
EBOD Format, Scoring and Revision Planning Eligibility, Applications and the Diploma Online Rules, Technical Preparation and Appeals
2 Chapter 2: Physical Optics, Photometry and Lenses
Light, refraction and total internal reflection Photometry, contrast, colour and adaptation Prisms, decentration and vector combination Vergence, astigmatic lenses and Sturm’s conoid
3 Chapter 3: Instrument Optics, Aberrations and Laser Physics
Cross-cylinder and diagnostic instrument optics Aberrations, duochrome and wavefront analysis Diffraction, polarization, lasers and OCT
4 Chapter 4: Refraction, Accommodation and Spectacle Prescribing
Objective and cycloplegic refraction Subjective refraction and binocular balance Accommodation, presbyopia and vertex distance Spectacle Materials, Measurement and Progressive Lenses
5 Chapter 5: Contact Lenses and Low-Vision Rehabilitation
Contact-lens optics, materials and tear lenses Contact-lens fit and complications Low-vision assessment and magnification Low-vision aids, calculations and ergonomics
6 Chapter 6: Extraocular Anatomy and Motor Physiology
Extraocular muscle anatomy and innervation Eye axes, kinematics and muscle actions Motor laws and orbital pulleys
7 Chapter 7: Binocular Vision and Amblyopia
Binocular vision, stereopsis and the horopter Suppression, correspondence and microtropia Sensory tests and amblyopia treatment
8 Chapter 8: Childhood Assessment and Strabismus Testing
Visual Development, Childhood Testing and Developmental Delay History, corneal reflexes and cover tests Motility patterns, three-step testing and Hess charts
9 Chapter 9: Esotropia, Exotropia and Vertical Deviations
Infantile and accommodative esotropia Exotropia classification and management Vertical Deviations, A–V Patterns and Skew
10 Chapter 10: Dysinnervation, Nystagmus and Muscle Surgery
Duane syndrome, Brown syndrome and restriction Nystagmus patterns and investigation Nystagmus and muscle surgery principles
11 Chapter 11: ROP and Paediatric Ocular Disease
Retinopathy of Prematurity: Screening, Classification and Follow-up Childhood Cataract, Leukocoria and Congenital Glaucoma Childhood Systemic Disease, Infection and Safeguarding
12 Chapter 12: Ocular Surface Anatomy and Infection
Corneal, Conjunctival and Scleral Structure: Examination and Sampling Bacterial keratitis, sampling and treatment Fungal, amoebic and herpetic keratitis Infectious, chlamydial and neonatal conjunctivitis
13 Chapter 13: Allergy, Cicatrisation and Surface Inflammation
Allergic eye disease, trachoma and phlyctenules Cicatrising Conjunctivitis: Mucous Membrane Pemphigoid and SJS/TEN Dry eye, blepharitis and meibomian dysfunction PUK, interstitial keratitis and scleritis
14 Chapter 14: Anterior Segment Dysgenesis and Corneal Dystrophies
Anterior Segment Dysgenesis, Aniridia and Congenital Corneal Opacity IC3D and epithelial or Bowman-layer dystrophies Stromal corneal dystrophies Endothelial corneal dystrophies
15 Chapter 15: Corneal Degeneration, Ectasia and Epithelial Failure
Corneal Degenerations, Pterygium, Band Keratopathy and Dellen Keratoconus and clinical ectasia signs Ectasia imaging, cross-linking and rehabilitation Recurrent Erosion, Neurotrophic Keratopathy and Vitamin A Deficiency
16 Chapter 16: Surface Reconstruction and Keratoplasty
Limbal Stem-Cell Failure, Tarsorrhaphy and Phototherapeutic Keratectomy PK, DALK and endothelial keratoplasty Corneal graft immunity and rejection recognition Graft rejection treatment and postoperative problems
17 Chapter 17: Lens Development, Cataract Assessment and Biometry
Lens Development, Congenital Shape and Ectopia Lentis Lens anatomy and age-related cataract phenotypes Cataract grading, secondary causes and childhood disease Optical and ultrasound biometry
18 Chapter 18: IOL Planning and Phacoemulsification
Keratometry and IOL power formulae Post-refractive biometry, toric alignment and IOL design Phaco fluidics and ultrasound delivery Wounds, OVDs and nucleus techniques
19 Chapter 19: Cataract Anaesthesia and Surgical Complications
Cataract Anaesthesia, Alternative Extraction and Combined Procedures IFIS, capsule rupture and compromised support Postoperative inflammation, haemorrhage and PCO
20 Chapter 20: Corneal and Intraocular Refractive Surgery
Excimer ablation, PRK and LASIK SMILE, surgical selection and complications Phakic IOLs and refractive lens exchange
21 Chapter 21: Presbyopia Procedures and Surface Therapeutics
Presbyopia Surgery, Monovision and Historical Refractive Procedures Surface antimicrobial and anti-inflammatory pharmacology Surface healing, amnion and cenegermin
22 Chapter 22: Aqueous Dynamics, Tonometry and Gonioscopy
Ciliary body and aqueous secretion Outflow and the Goldmann pressure model Tonometry, corneal thickness and biomechanics Gonioscopy optics, landmarks and indentation
23 Chapter 23: Angle, Disc and Visual-Field Assessment
Angle grading and anterior-segment imaging Optic-disc examination and documentation OCT and automated perimetry
24 Chapter 24: Glaucoma Progression, Suspects and Secondary Mechanisms
Field reliability and progression Ocular hypertension, suspects and juvenile glaucoma Lens-related glaucoma, aqueous misdirection and venous pressure
25 Chapter 25: POAG, Angle Closure and Pigmentary Disease
POAG, target pressure and normal-tension disease Angle-closure classification and mechanisms Acute angle closure, iridotomy and lens extraction Pseudoexfoliation and pigmentary glaucoma
26 Chapter 26: Glaucoma Medical, Laser and Surgical Treatment
Neovascular, uveitic and steroid-response glaucoma Glaucoma medicines, SLT and MIGS Trabeculectomy and drainage implants Nonpenetrating surgery, cyclodestruction and postoperative lasers
27 Chapter 27: Retinal Imaging, Diabetes and Vascular Occlusion
Retinal anatomy, examination and multimodal imaging Diabetic microangiopathy and NPDR classification PDR, macular oedema and diabetic trials Retinal vein and artery occlusions
28 Chapter 28: Uncommon Vascular Disease and Myopic Maculopathy
Macroaneurysm, sickle retinopathy and retinal periphlebitis Coats disease and leukocoria assessment MacTel and radiation retinopathy Myopic maculopathy and presumed ocular histoplasmosis
29 Chapter 29: Inherited Retina and Electrophysiology
Retinitis pigmentosa and inherited degeneration Stargardt, Best disease and retinal electrophysiology Cone disorders, stationary night blindness and syndromic retina
30 Chapter 30: AMD, Geographic Atrophy and Pachychoroid
AMD biology and clinical staging Drusen, geographic atrophy and neovascular phenotypes Neovascular AMD trials and treatment CSCR and the pachychoroid spectrum
31 Chapter 31: Retinal Breaks and Detachment Repair
PVD, peripheral degenerations and retinal breaks RRD localization and retinoschisis Detachment mechanisms, pneumatic retinopexy and scleral buckling
32 Chapter 32: Vitrectomy, Macular Surgery and Retinal Trauma
Vitrectomy and intraocular tamponades ERM, macular holes and PVR Retinal trauma, optic-disc pits and choroidal detachment
33 Chapter 33: Uveitis Classification and Non-Infectious Inflammation
SUN classification, grading and uveitis work-up Anterior and intermediate uveitis patterns HLA-B27, sarcoidosis, Behçet disease and VKH Posterior inflammatory patterns and immunomodulation
34 Chapter 34: Infectious Uveitis and Endophthalmitis
Toxoplasmosis and herpetic necrotizing retinitis Ocular syphilis and tuberculosis Immunosuppressed retinitis, toxocariasis and neuroretinitis Endophthalmitis diagnosis and treatment
35 Chapter 35: Optic Neuritis and Ischaemic Optic Neuropathy
Typical optic neuritis and ONTT NMOSD and MOGAD Arteritic optic neuropathy and GCA NAION and ischaemic neuropathy comparison
36 Chapter 36: Papilloedema, IIH and Afferent Localisation
Papilloedema recognition and Frisén grading IIH diagnosis and vision protection Disc drusen and pseudopapilloedema Afferent pathways and chiasmal localization
37 Chapter 37: Congenital, Inherited and Cortical Neuro-Ophthalmology
Cortical vision and higher visual syndromes Neuro-ophthalmic testing and congenital optic discs Inherited, compressive, infiltrative and nutritional optic neuropathies Transient visual loss, headache and neurological emergencies
38 Chapter 38: Central Motor Control and Cranial Nerve Palsies
Central ocular motor control and supranuclear disorders Third- and fourth-nerve palsies Sixth nerve, pontine gaze and cavernous sinus
39 Chapter 39: Myasthenia and Ocular Myopathy
Myasthenic ocular weakness Myasthenia testing and treatment Myopathy, CPEO and Kearns–Sayre syndrome
40 Chapter 40: Pupillary Pathways and Anisocoria
Pupillary pathways and afferent defects Horner syndrome and tonic pupil Light–near dissociation and pupil differentials
41 Chapter 41: Orbit, Thyroid Eye Disease and Ptosis Assessment
Orbital anatomy and thyroid eye disease Orbital infection and idiopathic inflammation Orbital masses, approaches and eye-removal procedures Lid anatomy and ptosis evaluation
42 Chapter 42: Lid Repair and Lacrimal Drainage
Ptosis repair, malposition and eyelid tumours Lash disorders, facial palsy and lid reconstruction Lacrimal drainage and epiphora testing Nasolacrimal obstruction, infection and DCR
43 Chapter 43: Lacrimal Gland Disease, Pathology and Intraocular Tumours
Lacrimal gland inflammation and tumours Ocular histology, specimen handling and special stains Immunophenotyping, molecular pathology and tumour genetics Uveal melanoma and retinoblastoma
44 Chapter 44: Lymphoma, Surface Tumours and Paraneoplastic Disease
Vitreoretinal lymphoma Surface tumours, uveal metastases and benign mimics Paraneoplastic retinopathy, treatment effects and counselling
45 Chapter 45: Ocular Trauma and Vascular Systemic Disease
Trauma terminology and prognostic scoring Chemical injury and surface preservation Open-globe emergency management Vascular, endocrine, pregnancy and renal eye disease
46 Chapter 46: Multisystem Disease and Ophthalmic Pharmacology
Immune, metabolic and multisystem ocular clues Phakomatoses and syndrome-specific surveillance Connective-tissue and metabolic ocular disease Drug delivery and systemic glaucoma effects
47 Chapter 47: Medication Toxicity, Professional Practice and Clinical Stations
Retinal and optic medication toxicity Prevention, consent and professional practice Directed clinical answers and station rehearsal
Typical optic neuritis and ONTT
Key Takeaways Explain This Topic AI
Typical demyelinating optic neuritis combines a compatible clinical course with exclusion of atypical causes.
ONTT distinguished high-dose treatment from the low-dose oral-only regimen tested in that study.
Visual recovery can be good despite persistent contrast, colour or other deficits, and MRI findings influence neurological assessment.
Last updated: October 2026
Introduction to Demyelinating Optic Neuropathies
Optic neuritis encompasses an inflammatory, demyelinating insult directed against the optic nerve (cranial nerve II). As an evagination of the diencephalon, the optic nerve is an anatomical tract of the central nervous system (CNS). Its axons are myelinated by oligodendrocytes rather than Schwann cells, and it is sheathed by all three meningeal layers (pia, arachnoid, and dura mater) with surrounding cerebrospinal fluid (CSF) in the perioptic subarachnoid space. Demyelinating optic neuritis is the most frequent acute optic neuropathy encountered in young adults, serving as the initial presenting manifestation in approximately 20% of Multiple Sclerosis (MS) patients and occurring during the disease course in up to 50%.
In recent years, the clinical paradigm has shifted from viewing optic neuritis solely as a monosymptomatic manifestation of MS to recognizing distinct pathophysiological autoimmune entities: Multiple Sclerosis-associated Optic Neuritis (MS-ON) , Neuromyelitis Optica Spectrum Disorder (NMOSD) , and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) . Differentiating these conditions at presentation is paramount, as their visual prognoses, neuro-imaging patterns, and therapeutic responses diverge radically.
- Typical Demyelinating Optic Neuritis
- Epidemiology & Demographics
Typical demyelinating optic neuritis exhibits a pronounced epidemiological profile:
Age: Predominantly young adults aged 20 to 40 years (peak incidence in the early 30s; uncommon below age 12 or above age 50).
Sex: Strong female preponderance, with a female-to-male ratio of approximately 3:1.
Geography: Higher prevalence in populations of Northern European descent and temperate latitudes, reflecting the epidemiological distribution of Multiple Sclerosis.
Clinical Presentation & Cardinal Signs
The clinical syndrome of typical optic neuritis is characterised by a constellation of five cardinal clinical features:
Subacute, Unilateral Vision Loss: Visual acuity loss is typically acute or subacute, progressing over several hours to days. It characteristically reaches its nadir within 1 to 2 weeks of onset. Visual acuity impairment varies widely: in the landmark Optic Neuritis Treatment Trial (ONTT), approximately 10% presented with 20/20 or better visual acuity, 29% presented with 20/25 to 20/40, 26% with 20/50 to 20/190, and 35% with 20/200 or worse (including light perception).
Orbital Pain Exacerbated by Eye Movements (92%): Present in the vast majority of patients. The discomfort is classically described as a dull, retro-orbital or periorbital ache, which is characteristically aggravated by ocular movements, especially elevation and adduction. Anatomically, this reflects mechanical traction exerted by the origins of the superior and medial rectus muscles directly on the inflamed, sensitized optic nerve sheath at the orbital apex and annulus of Zinn.
Profound Dyschromatopsia (Red Desaturation): Color vision impairment is characteristically out of proportion to the loss of Snellen visual acuity. Patients experience profound desaturation of red hues, which can be rapidly evaluated at the bedside by presenting a bright red object (such as a mydriatic bottle cap) sequentially to each eye. The patient typically describes the target in the affected eye as washed-out, orange, pink, or brownish-gray.
Relative Afferent Pupillary Defect (RAPD / Marcus Gunn Pupil): An RAPD is an indispensable diagnostic finding in unilateral or asymmetrical bilateral disease in the presence of an otherwise normal fellow eye. During the swinging flashlight test, light shifted from the unaffected to the affected eye elicits paradoxical bilateral pupillary dilatation rather than constriction, demonstrating impaired afferent conduction along cranial nerve II.
Visual Field Defects: Although central and centrocaecal scotomas are considered the classic perimetric hallmarks (reflecting preferential inflammation of the papillomacular bundle), the ONTT revealed that virtually any visual field defect can occur. Diffuse generalized depression, three-quadrant depression, arcuate (nerve fibre bundle) scotomas, and altitudinal defects are commonly recorded.
Fundus Appearance: Retrobulbar vs. Papillitis
Ophthalmoscopic evaluation reveals two distinct anatomical presentations:
Retrobulbar Optic Neuritis (Two-Thirds / ~65%): The inflammatory focus is situated posterior to the globe. Slit-lamp biomicroscopy and indirect ophthalmoscopy reveal a completely normal optic disc, crisp margins, and normal retinal vasculature. This gives rise to the classic clinical aphorism: "The doctor sees nothing, and the patient sees nothing."
Anterior Papillitis (One-Third / ~35%): The inflammatory process involves the optic nerve head. Fundus examination reveals mild-to-moderate optic disc hyperaemia, oedematous blurred disc margins, distension of peripapillary retinal venules, and occasional peripapillary splinter haemorrhages. Vitreous cells are typically absent or exceedingly sparse; prominent vitritis or macular exudative star formation should prompt immediate consideration of alternative diagnoses (such as neuroretinitis, cat-scratch disease, or sarcoidosis).
Landmark Findings of the Optic Neuritis Treatment Trial (ONTT)
The Optic Neuritis Treatment Trial (ONTT), initiated in 1988 under the leadership of Roy Beck, is the definitive multicentre randomised trial that established modern management protocols and long-term prognostic understanding of demyelinating optic neuritis.
Study Design & Treatment Arms
The ONTT enrolled 457 patients aged 18 to 46 years presenting within 8 days of acute unilateral optic neuritis. Patients were randomised to one of three treatment regimens:
Oral Prednisone Arm: Oral prednisone alone at standard doses (1 mg/kg/day) for 14 days, followed by a 4-day taper.
Intravenous Methylprednisolone Arm: High-dose IV methylprednisolone (250 mg every 6 hours / 1,000 mg daily) for 3 days, followed by oral prednisone (1 mg/kg/day) for 11 days, followed by a 4-day taper.
Oral Placebo Arm: Inactive placebo tablets matching the oral prednisone schedule.
The Three Core Findings of the ONTT
Oral Prednisone Alone is Contraindicated: Oral prednisone administered in standard dosages (1 mg/kg/day) without preceding high-dose intravenous therapy did not improve the rate or degree of visual recovery compared to placebo. Critically, it doubled the rate of recurrent optic neuritis at 2 years (30% recurrence rate in the oral prednisone cohort vs. 16% in the placebo group and 13% in the IV group). Consequently, standard-dose oral prednisone alone is strictly contraindicated in acute typical optic neuritis.
High-Dose IV Corticosteroids Accelerate Recovery Speed Only: Intravenous methylprednisolone followed by oral prednisone accelerated the speed of visual recovery, allowing patients to regain visual acuity and contrast sensitivity several weeks faster than the placebo group. However, by 6 to 12 months, and maintained throughout the 5-, 10-, and 15-year follow-up intervals, there was no statistically significant difference in final visual acuity, visual field sensitivity, or contrast sensitivity between the IV steroid and placebo arms. High-dose IV methylprednisolone acts to hasten recovery, but does not alter long-term structural or visual outcomes.
Brain MRI is the Single Most Powerful Predictor of Multiple Sclerosis: Baseline brain magnetic resonance imaging (MRI) with gadolinium enhancement is the most vital prognostic investigation. The ONTT demonstrated that the 15-year cumulative risk of developing clinically definite Multiple Sclerosis (CDMS) is strictly stratified by the presence and quantity of baseline demyelinating white matter lesions:
0 Lesions on Baseline Brain MRI: 15-year risk of developing MS is 25% .
≥ 1 \ge 1 ≥ 1 Lesion on Baseline Brain MRI: 15-year risk of developing MS rises to 72% .
Important
Typical demyelinating white matter lesions on brain MRI are defined as ovoid, hyperintense areas on T2-weighted and FLAIR sequences measuring ≥ 3 mm \ge 3\text{ mm} ≥ 3 mm in diameter, located in the periventricular, juxtacortical, or infratentorial regions. Periventricular lesions oriented perpendicularly along medullary venules are termed Dawson's fingers .
Visual Recovery & Subclinical Residual Phenomena
The natural history of typical demyelinating optic neuritis is overwhelmingly favourable. Over 90% of patients achieve visual acuity of 20/40 or better within 6 to 12 months, and over 70% regain 20/20 or better. However, fine functional deficits frequently persist indefinitely due to subclinical axonal loss and persistent myelin thinning:
Contrast Sensitivity & Stereoacuity Deficits: Many patients continue to complain of subjective "dimness" or reduced image quality despite 20/20 Snellen acuity.
Delayed Visual Evoked Potentials (VEP): Prolongation of the P100 latency persists permanently on pattern VEP, demonstrating chronic conduction delay along remyelinated axons.
Uhthoff's Phenomenon: Transient, reversible deterioration of vision (or other neurological functions) precipitated by an elevation in core body temperature (e.g., following physical exercise, taking a hot bath, or experiencing a febrile illness). Elevated temperature diminishes the safety factor of action potential propagation across chronically demyelinated axonal segments.
Pulfrich Phenomenon: An altered stereo-perception of motion in depth resulting from asymmetrical inter-ocular conduction velocities. A pendulum swinging perpendicularly across the visual field appears to the patient to move in an elliptical path, which can cause depth-perception disorientation when driving or catching moving objects.